Saple, D. G., Save, S., Kumar, D., & Sood, S. (2022). An open label, single arm, pilot study to evaluate the safety, tolerability, and efficacy of daily fluconazole 150 mg in subjects suffering from Tinea cruris and Tinea corporis [version 1; peer review: Awaiting peer review]. F1000 research, 11, 1446. https://doi.org/10.12688/f1000research.127138.1
Citace podle Chicago (17th ed.)Saple, Dattatray Gopal, Sushrut Save, Devesh Kumar, a Suneet Sood. "An Open Label, Single Arm, Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of Daily Fluconazole 150 Mg in Subjects Suffering from Tinea Cruris and Tinea Corporis [version 1; Peer Review: Awaiting Peer Review]." F1000 Research 11 (2022): 1446. https://doi.org/10.12688/f1000research.127138.1.
Citace podle MLA (9th ed.)Saple, Dattatray Gopal, et al. "An Open Label, Single Arm, Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of Daily Fluconazole 150 Mg in Subjects Suffering from Tinea Cruris and Tinea Corporis [version 1; Peer Review: Awaiting Peer Review]." F1000 Research, vol. 11, 2022, p. 1446, https://doi.org/10.12688/f1000research.127138.1.